Synapse - Robert Motzer

Results (84)

Single-center analysis of 109 patients (pts) with metastatic chromophobe renal cell carcinoma (ChRCC): Differences in outcomes by histologic variant

Meeting Abstract

Ged, Y.; Knezevic, A.; Chen, Y.; Redzematovic, A.; Carlo, M. I.; Lee, C. H.; Feldman, D. R.; Patil, S.; Motzer, R. J.; Voss, M. H.
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Everolimus (E) plus bevacizumab (B) is effective first-line treatment for patients (pts) with advanced renal cell carcinoma (RCC) with papillary features (PF): Results from a phase II trial

Meeting Abstract

Feldman, D. R.; Lee, C. H.; Molina, A. M.; Knezevic, A.; Chen, Y.; Chaim, J.; Coskey, D. T.; Ged, Y.; Tickoo, S.; Reuter, V. E.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Outcomes of metastatic chromophobe renal cell carcinoma (ChRCC) with sarcomatoid features (SF)

Meeting Abstract

Ged, Y.; Knezevic, A.; Chen, Y.; Redzematovic, A.; Carlo, M. I.; Lee, C. H.; Feldman, D. R.; Patil, S.; Motzer, R. J.; Voss, M. H.
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Comparative genomic profiling of matched primary and metastatic tumors in renal cell carcinoma

Journal Article

Becerra, M. F.; Reznik, E.; Redzematovic, A.; Tennenbaum, D. M.; Kashan, M.; Ghanaat, M.; Casuscelli, J.; Manley, B.; Jonsson, P.; DiNatale, R. G.; more...
European Urology Focus (2018)

Fulltext@MSK | Save

Prevalence of germline mutations in cancer susceptibility genes in patients with advanced renal cell carcinoma

Journal Article

Carlo, M. I.; Mukherjee, S.; Mandelker, D.; Vijai, J.; Kemel, Y.; Zhang, L.; Knezevic, A.; Patil, S.; Ceyhan-Birsoy, O.; Huang, K. C.; more...
JAMA Oncology (2018)

Fulltext@MSK | Save

Genomic alterations and outcomes with VEGF-targeted therapy in patients with clear cell renal cell carcinoma

Journal Article

Carlo, M. I.; Manley, B.; Patil, S.; Woo, K. M.; Coskey, D. T.; Redzematovic, A.; Arcila, M.; Ladanyi, M.; Lee, W.; Chen, Y. B.; more...
Kidney Cancer (2017)

Fulltext@MSK | Save

Discovery and prevalence of cancer-susceptibility germline mutations (Mts) in patients (Pts) with advanced renal cell carcinoma (aRCC)

Meeting Abstract

Carlo, M. I.; Mukherjee, S.; Kemel, Y.; Zhang, L.; Mandelker, D.; Vijai, J.; Coskey, D. T.; Pradhan, N.; Hyman, D. M.; Hakimi, A. A.; more...
Journal of Clinical Oncology (2017)

Fulltext@MSK | Save

Genomic characterization of renal medullary carcinoma and treatment outcomes

Journal Article

Carlo, M. I.; Chaim, J.; Patil, S.; Kemel, Y.; Schram, A. M.; Woo, K.; Coskey, D.; Nanjangud, G. J.; Voss, M. H.; Feldman, D. R.; more...
Clinical Genitourinary Cancer (2017)

Fulltext@MSK | Save

Mutation detection in patients with advanced cancer by universal sequencing of cancer-related genes in tumor and normal DNA vs guideline-based germline testing

Journal Article

Mandelker, D.; Zhang, L.; Kemel, Y.; Stadler, Z. K.; Joseph, V.; Zehir, A.; Pradhan, N.; Arnold, A.; Walsh, M. F.; Li, Y.; more...
JAMA - Journal of the American Medical Association (2017)

Fulltext@MSK | Save

Genomic alterations as predictors of survival among patients within a combined cohort with clear cell renal cell carcinoma undergoing cytoreductive nephrectomy

Journal Article

Tennenbaum, D. M.; Manley, B. J.; Zabor, E.; Becerra, M. F.; Carlo, M. I.; Casuscelli, J.; Redzematovic, A.; Khan, N.; Arcila, M. E.; Voss, M. H.; more...
Urologic Oncology: Seminars and Original Investigations (2017)

Fulltext@MSK | Save